ANDRÉ BIROTTE JR., District Judge.
Pending before the Court is the Employment Retirement Income Security Act ("ERISA") action concerning the termination of Plaintiff Kanika Bledsoe's ("Plaintiff") long-term disability ("LTD") benefits, pursuant to 29 U.S.C. § 1132(a)(1)(B). (See Complaint, Dkt. No. 1.) Plaintiff seeks reinstatement of the LTD benefits under an ERISA-governed benefit plan ("Plan"). Defendants Metropolitan Life Insurance Company ("MetLife") and Colgate-Palmolive Company (collectively "Defendants") operate as the administrators of claims made under the Plan. On October 27, 2014, Plaintiff filed a Motion for Summary Judgment, which has now been converted to a trial brief. (Pl. Br., Dkt. No. 38.) On November 3, 2014, Defendants filed an opposition to the Motion for Summary Judgment, which has now been converted to a trial brief. (Def. Br., Dkt. No. 44.) On November 10, 2014, Plaintiff filed a Reply, which has now been converted as a responsive trial brief. (Pl. Reply, Dkt. No. 47.) An Administrative Record ("AR") was submitted on October 29, 2014. (Dkt. No. 44.) A bench trial commenced on January 5, 2015. (Dkt. No. 54.) Upon reviewing the Parties' trial briefs and the Administrative Record, the Court finds for Plaintiff and the LTD Benefits are hereby reinstated.
"In bench trials, Fed.R.Civ.P. 52(a) requires a court to `find the facts specially and state separately its conclusions of law thereon.'" Vance v. American Hawaii Cruises, Inc., 789 F.2d 790, 792 (9th Cir. 1986) (quoting Fed.R.Civ.P. 52(a)). "One purpose behind Rule 52(a) is to aid the appellate court's understanding of the basis of the trial court's decision. This purpose is achieved if the district court's findings are sufficient to indicate the factual basis for its ultimate conclusions." Id. (citations omitted). The following constitutes the findings of fact within the AR.
This action is brought forth in an effort to reinstate Plaintiff's welfare benefit plan under ERISA. (See Compl.)
MetLife issued the Colgate-Palmolive Welfare Benefit Plan, Group Policy No. 106240-1-G, to Plaintiff's former employer Colgate-Palmolive. (Administrative Record ("AR"), 1-86.)
The Colgate-Palmolive Welfare Benefit Plan sets forth the following provision:
(AR 25.)
On May 14, 2007, Plaintiff began working for Colgate-Palmolive Company. (AR 1191, 1403.) As the Account Business Manager, Plaintiff's job description is as follows:
(AR 1115.)
On August 17, 2009, Plaintiff stopped working for Colgate-Palmolive Company because Plaintiff was unable to perform her occupational duties due to "systemic lupus erythematosus" causing "severe fatigue, inflammatory arthritis." (AR 1348-1349.)
Because of her inability to work, Plaintiff initiated a short-term disability ("STD") benefits plan with MetLife, lasting six (6) months. (AR 1335, 1291, 1271.) According to the Plan, "STD benefits are payable for up to 180 days as long as you are considered disabled under the Plan. After 180 days, if you remain disabled, you may be eligible for benefits under the LTD Plan." (AR 73.) The benefits began on August 18, 2009 and continued through February 13, 2010. (AR 1271, 1281, 1290.) Consequently, Plaintiff initiated the LTD benefits plan with MetLife. (AR 1178-1193.)
On January 21, 2010, MetLife's claim examiner spoke with a MetLife nurse consultant who concluded that "[b]ased on [the medical file], [Plaintiff] is severe with kidney failure and in active chemo to treat her Lupus. NC [nurse consultant] indicates that it is reasonable to consider [Plaintiff] disabled." (AR 1405.)
On January 27, 2010, MetLife approved Plaintiff's LTD benefits plan. (AR 1130-1132.) The letter approving her LTD claim stated, "[y]ou became disabled on August 18, 2009. After satisfaction of the required 180 day elimination period, benefits are payable as of February 14, 2010." (AR 1130.)
In April 2010, after Plaintiff informed MetLife that she was approved for State Disability Insurance ("SDI"), MetLife informed Plaintiff that it would be offsetting Plaintiff's LTD benefits with the SDI benefits. (AR 1124-1125.)
In December 2010, Plaintiff informed MetLife that she was approved and would be receiving Social Security Disability Insurance ("SSDI") in the amount of $2,173.00. (AR 1058-1061.) In a January 5, 2011 letter, MetLife informed Plaintiff that it would be offsetting Plaintiffs LTD benefits with the SSDI benefits she was receiving. (AR 1052-1053.)
On December 13, 2011, Plaintiffs primary treating physician, Dr. Shuntaro Shinada, submitted a Physician Statement stating that Plaintiff was "expect[ing] improvement
On February 13, 2012, MetLife informed Plaintiff that "[Plaintiffs] claim is terminated effective today as the restrictions received from Dr. Shinada no longer supports your disability." (AR 875.)
On April 11, 2012, Plaintiff appealed MetLife's termination-of-benefits decision. (AR 855.) Plaintiff's appeal consisted of a letter and additional medical records of her treating physician, Dr. Shinada, which stated,
(AR 855.)
To supplement her appeal, Plaintiff submitted her Social Security Administration decision approving her SSDI benefits plan. (AR 844-849.) The decision stated "[Plaintiff] has the following severe impairments: systemic lupus erythematosus, lupus nephritis, lupus cerebritis and polyarthritis... [Plaintiff] cannot perform sustained work activity for 8 hours a day 5 days a week." (AR 846.)
On May 4, 2012, MetLife received opinions from Tracey Schmidt, M.D., certified in internal medicine and rheumatology. (AR 836-838.) Dr. Schmidt's opinion stated the following about Plaintiff's diagnosis,
(AR 838.)
In a May 10, 2012 letter, MetLife informed Plaintiff of the following, "[i]t has been determined that the previous claims decision will be reversed and the benefits will be reinstated." (AR 828.) On May 15, 2012, MetLife continued to state "[MetLife] [is] reinstating your [LTD] claim with no lapse in coverage. We have also completed our review to determine if you are totally disabled from performing any occupation. Based upon our review, continued LTD benefits have been approved at this time." (AR 823-824.)
On August 27, 2012, Plaintiff informed MetLife that she had returned to work full-time for DeVry on August 23, 2012. (AR 1604-1605, 790.) Based on that information, MetLife closed Plaintiff's LTD Benefits claim as of August 22, 2012. (AR 790.)
At DeVry, Plaintiff was a manager of local account, which involved traveling and cold calling different government entities about DeVry. (AR 1618.) Plaintiff would stand on her feet between two to six (2-6)
On November 12, 2012, Plaintiff went to the emergency room complaining of chest pains. (AR 769.) On November 19, 2012, Plaintiff informed MetLife that she had to stop working full-time due to recurrent symptoms of Lupus. (AR 1610-1611, 763.)
On November 27, 2012, through a letter and a medical report, Dr. Shinada informed MetLife of the following:
(AR 767-771.)
In response, on January 22, 2013, MetLife advised Plaintiff that she had not established a basis for a recurrent disability. (AR 763-765.) Specifically, MetLife explained to Plaintiff the following:
(Id.)
In July 2013, Plaintiff appealed MetLife's determination and retained counsel to carry out the appeal. (AR 200-206.) On July 18, 2013, an appeal letter as well as 506 supporting documents were sent to MetLife. (AR 207-711.) The letter stated the following:
(AR 201-203.)
Within the records of the appeal, Dr. Shinada authored a July 10, 2013 letter expressing concern about the potential impact of another flare-up of Plaintiffs lupus. (AR 209-210.) With respect to Plaintiffs condition, Dr. Shinada stated,
(Id.)
To further supplement her appeal, Paul Broadus, a vocational expert with Broadus & Associates, completed an Employability Analysis on July 17, 2013, which stated the following,
(AR 698-706.)
As part of its review of the administrative appeal, MetLife advised Plaintiff that MetLife would render its decision with the assistance of an "Independent Physician Consultant" from Network Medical Review Co. Ltd. ("NMR"). (AR 196.) The physician of NMR is named Rajendra Marwah, M.D. Dr. Marwah is board certified in internal medicine and rheumatology. (AR 177-189.)
Dr. Marwah sent a report to MetLife evaluating Plaintiff. (Id.) Within the report, Dr. Marwah related his telephone conversation with Dr. Shinada during which they discussed Plaintiff's diagnoses, symptoms and reasons why she could not return to work. (AR 147.) The phone conversation lasted ten (10) minutes. (Id.) Dr. Marwah noted the following:
(Id.)
Based on the conversation with Dr. Shinada, Dr. Marwah concluded the following:
(AR 154.)
Plaintiff's attorneys and Dr. Shinada submitted responses to Dr. Marwah's report, which were provided to Dr. Marwah. (AR 107-108.) In considering these responses, Dr. Marwah stated Dr. Shinada's opinion of Plaintiff remaining off work from November 10, 2012 through November 19, 2013 "is purely subjective and has no objective basis or rationale." (AR 107.) Dr. Marwah concluded that his findings "remain unaltered upon review of Dr. Shinada's critique...." (AR 108.)
To assist in the review of the appeal, MetLife also employed CorVel Corporation ("CorVel"), a Vocational Rehabilitation Consultant, to conduct an employability and labor market analysis. (AR 133.) CorVel uses a software program that matches a worker's skills and abilities to occupations listed in the Dictionary of Occupational titles, and provides crosswalks to Occupational Employment Statistic data, Occupational Outlook projections, Job Banks, and other sources of occupational information. (Id.) Considering the skills, abilities, and medical history of Plaintiff, CorVel concluded that Plaintiff has the functional ability to work at different sedentary positions such as Manager of Sales, Contract Administrator, Manager of Advertising, and a Manager of Merchandise. (Id.) All the positions are sedentary positions because of Plaintiffs systemic lupus erythematous. (Id.)
Considering the reports above and Plaintiff's entire file, on October 24, 2013, MetLife rendered its final decision regarding
(Id.)
As a result of MetLife's final ruling, Plaintiff filed suit in this court on December 11, 2013. (See Compl.)
Under Federal Rules of Civil Procedure ("FRCP") 52, the Parties move for judgment in their respective favors regarding Plaintiff's ERISA claims. Under FRCP 52, the Court conducts a bench trial on the record, evaluating the persuasiveness of the arguments and deciding which is more likely true. Kearney v. Standard Ins. Co., 175 F.3d 1084, 1094-95 (9th Cir. 1999).
In implementing ERISA, Congress intended to adopt a uniform set of standards in the administration of employee benefit plans. Menhorn v. Firestone Tire & Rubber Co., 738 F.2d 1496, 1498 (9th Cir.1984). Congress empowered federal courts to develop a body of federal common law consistent with ERISA's purpose. Schikore v. BankAmerica Supplemental Retirement Plan, 269 F.3d 956, 962 (9th Cir.2001).
Under ERISA, a beneficiary may sue "to recover benefits due to him under the terms of his plan, to enforce his rights under the terms of the plan, or to clarify his rights to future benefits under the terms of the plan." 29 U.S.C. § 1132(a)(1)(B).
A court reviews the benefit plan de novo "unless the benefit plan gives the administrator or fiduciary discretionary authority to determine eligibility for benefits;" if the plan does grant such discretionary authority, the Court reviews the administrator's decision for abuse of discretion. See Firestone Tire & Rubber Co. v. Bruch, 489 U.S. 101, 115, 109 S.Ct. 948, 103 L.Ed.2d 80 (1989); Salomaa v. Honda Long Term Disability Plan, 642 F.3d 666, 675 (9th Cir.2011).
On July 10, 2014, this Court ruled that the standard for judicial review is de novo. (Dkt. No. 35.) The Court determines whether the plaintiff is entitled to benefits based on the evidence in the administrative record. Kearney, 175 F.3d at 1087-1090.
Under the de novo standard of review, the Court gives no deference to MetLife's decision in terminating Plaintiff's benefits. Instead, the Court must decide whether Plaintiff is entitled to benefits. "In an ERISA case involving de novo review, the plaintiff has the burden of showing entitlement to benefits." Schramm v. CNA Fin. Corp. Insured Grp. Ben. Program, 718 F.Supp.2d 1151, 1162 (N.D.Cal.2010); see also Muniz v. AMEC Constr. Mgmt., No. CV-07-8066 CAS (AJWx), 2009 U.S. Dist. LEXIS 26970,
The review is limited to the evidence in the administrative record. Opeta v. Nw. Airlines Pension Plan for Contract Employees, 484 F.3d 1211, 1217 (9th Cir. 2007). The Court analyzes the record anew and "evaluate[s] the persuasiveness of conflicting testimony and decide which is more likely true." Kearney, 175 F.3d at 1095.
The Court's review of the administrative record and the Parties' arguments establishes that, at the time Plaintiff's benefits were terminated, she was disabled under Defendant's plan definition.
The Plan defines disability as the following:
(AR 25.)
Spanning from 2009 to 2012, Plaintiff and MetLife have spiraled down a path of approvals and denials under the Plan. In determining whether Plaintiff was disabled at the time MetLife terminated her benefits, the Court begins with MetLife's STD benefits approval from August 18, 2009 through February 13, 2010. (AR 1271, 1281, 1290.) The medical file available to MetLife, at the time of the approval, indicated that Plaintiff was disabled. After the STD 180 day allotment under the Plan, on January 27, 2010, MetLife approved Plaintiff's LTD benefits plan. (AR 1130-1132.) On August 22, 2012, MetLife terminated Plaintiff's LTD Benefits Plan. (AR 790.) Therefore, during the period from August 18, 2009 until August 22, 2012, there is no dispute that Plaintiff was in fact disabled for which she received STD and LTD benefits.
Plaintiff argues that because MetLife was previously paying Plaintiff LTD benefits, MetLife has a higher burden in justifying the termination of benefits. (Pl. Br., p. 2); Saffon v. Wells Fargo & Co. Long Term Disability Plan, 522 F.3d 863, 871 (9th Cir.2008). Although Saffon does not mandate a higher burden of proof per se, its analysis is instructive.
In Saffon, the plaintiff suffered from a degeneration of her cervical spine, which granted her LTD benefits under the plan. Id. After paying LTD benefits for a year, the defendant informed the plaintiff that "she no longer m[et] the definition of disability" and terminated her LTD benefits. Id. at 866. After an unsuccessful appeal, the plaintiff sued, and a district court concluded that the defendant did not abuse its discretion. Id. On appeal, the Ninth Circuit remanded the case back to the district court in order to allow the plaintiff the opportunity to supplement the record with additional outside evidence. Id. at 873-874.
Here, the record up until this point clearly demonstrated Plaintiff's disability and as a result, MetLife provided STD and LTD for nearly three (3) years. See McOsker, 279 F.3d at 589. Therefore, this Court would expect MetLife to provide some evidence of Plaintiff's medical progression at the time of MetLife's termination of LTD benefits. Schramm, 718 F.Supp.2d at 1164 ("Although Defendant did not need to prove a material improvement in Plaintiff's condition to defeat her entitlement to benefits, her lack of consistent, marked progress is probative of her continuing disability.").
The Court's review of the administrative record strongly indicates that Plaintiff has a history of systemic lupus erythematosus. (See AR.) MetLife acknowledges that Defendant has lived with the systemic lupus erythematosus condition since being diagnosed in 1990. (Def. Br., p. 1 ("[Defendants] acknowledge that [Plaintiff] has a medical condition that she has lived with since 1990 (Lupus), and that she suffered a disabling flare up in August 2009.")). Plaintiff's treating physician, Dr. Shinada, is Plaintiff's primary source in identifying her with Lupus and substantiating her LTD benefits claim. Dr. Shinada has detailed the symptoms that Plaintiff has suffered from to include, but are not limited to, bad chest pains, migraine headaches, ongoing fatigue, arthritis and arthralgia, inflammatory rashes. (Id. at 201-203.) Dr. Shinada ultimately concludes that Plaintiff's condition precludes her from returning back to work. (AR 209-210.) Due to the incident on November 12, 2012, Dr. Shinada believes that Plaintiff may suffer from another flare up of her cerebritis, which may affect her mental function as well as may lead to neurological problems such as paralysis or stroke. (AR 202.)
Although their diagnoses somewhat differed, both physicians, Dr. Marwah and Dr. Shinada, agree that Plaintiff suffered from the symptoms mentioned above. Dr. Shinada has opined that Plaintiff suffered from "ongoing illnesses and conditions, including but not limited to systemic lupus erythematosus, class 4 lupus nephritis, lupus cerebritis with headache and pericardial effusion status post drainage as well as lupus-related headaches, severe fatigue, arthritis and arthralgia, inflammatory rash and chest pain." (AR 201-203.) Dr. Marwah
The Court contextualizes its analysis with the undisputed fact that Plaintiff suffers from lupus. "Physicians recognize lupus as an incurable autoimmune disease set off when something goes wrong with the body's immune system and antibodies that normally fight germs begin to attack healthy tissue." Kennedy v. Collagen Corporation, 161 F.3d 1226, 1229 (9th Cir. 1998); see also Lopez v. Colvin, No. ED CV 13-1753-DFM, 2014 WL 1370672, n. 2 (C.D.Cal. April 7, 2014) ("Lupus or systemic lupus erythematosus is a chronic autoimmune disease in which the body's immune system mistakenly attacks healthy tissue. The most common symptoms of lupus are joint pain, inflammation, and swelling." (citing Systemic Lupus Erythematosus, PubMed Health (last reviewed Feb. 21, 2013), http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001471/.)). It is evident to the Court that the chronic nature of the lupus condition causes the reoccurrence of the symptoms cited above. While MetLife claims that Dr. Shinada's reports have been inconsistent (Def. Br., p. 13), the symptoms manifestly improve and digress at various times, in fact Dr. Shinada has reported that Plaintiff may have "good days" and "bad days" with her disability. (AR 216.)
MetLife asserts various arguments. MetLife contends that Plaintiff's medical condition alone does not mean Plaintiff is disabled as defined in the Plan. (Id.) MetLife also argues that Plaintiff took a job that was not appropriate for her condition, which is why the incident occurred. (Bench Trial Transcript ("BT"), Dkt. No. 54.) Moreover, MetLife questions the linkage between the stress that caused the November 2012 incident and that of Plaintiff's lupus condition. (Id. at 15:5-16 ("In contrast when you look at the relevant time, November of 2012, there aren't biopsies or ultrasounds or lab work. There is no objective evidence saying she's in the middle of a flare-up ... if you look at the actual records ... there is really no evidence that this was a recurrence of lupus. It was stress. She took too stressful a job.")). MetLife's arguments of the lack of objective testing and the lack of evidence demonstrating that lupus caused November 2012's incident are consistent with Dr. Marwah's opinion.
In upholding the denial of benefits, MetLife relied on Dr. Marwah's opinion and the lack of objective testing on the part of Dr. Shinada. (AR-89-98.) Dr. Marwah concluded that no objective evidence supporting a disabling recurrence of lupus in November 2012 or thereafter could be found within Plaintiff's medical record, and that Plaintiff's condition more closely resembles fibromyalgia.
Plaintiff's condition has been supported through objective testing in the past, most recently between September 2009 and October 2009. (AR 149; 349-353.) For example, on September 18, 2009, Dr. Shinada examined Plaintiff's blood and urine chemistry to observe Plaintiff's white blood cell count, urine creatinine, and other antibodies that resembled signs of Lupus. (AR 351 ("Other antibodies that were tested was an anti-neural antibody which [was] positive [and] consistent with lupus cerebritis.")). On October 6, 2009, a nephrologist named Dr. Arshia Ghaffari conducted a kidney biopsy on Plaintiff, which also showed signs consistent with lupus. (AR 149 ("[Plaintiff] had a kidney biopsy performed on 10/06/09 that showed changes consistent with lupus nephritis class 4 with mild interstitial nephritis.")). Dr. Shinada also agreed with Dr. Ghaffari's findings, noting that "[Plaintiff] did have a kidney biopsy done [on] October 6, 2009, which showed adequate biopsy, 18-21 glomeruli present in different sections and 2 cores of renal cortex, diffuse segmental to global proliferative and sclerosing glomerulonephritis consistent with lupus nephritis class 4...." (AR 345.) MetLife argues that these objective measures that reinforced Plaintiff's disability need to be frequently taken in order to prove that Plaintiff has a disability. (Def. Br. pp. 10-11.) Yet, the Court does not see what Dr. Shinada and Plaintiff can accomplish by continuing to take objective testing after already objectively finding that Plaintiff suffers from this chronic illness. Dr. Shinada's opinions may primarily derive from Plaintiff's subjective complaints, but the subjective complaints sustain the objective testing previously explored. It is the objective testing that substantiated Plaintiff's condition, and Plaintiff's subjective complaints support those symptoms. The preponderance of the evidence within the AR suggests that Plaintiff's subjective complaints derive from Plaintiff's condition and the symptoms associated with that condition. See Salomaa v. Honda Long Term Disability Plan, 642 F.3d 666, 675-677 (9th Cir.2011) (The Ninth Circuit reversed the plan administrator's denial because each physician that examined the plaintiff determined that he was disabled and the plan administrator's demand for objective testing were illogical "because such objective measures as blood tests are used to rule out alternative diseases, not to establish the existence of [the medical condition]."); Oster v. Standard Insurance Company, 759 F.Supp.2d 1172, 1185 (N.D.Cal.2011) ("In an ERISA action, the plaintiff carries the burden of showing, by a preponderance of the evidence, that he was disabled under
The fact remains that over a three (3) year period the medical record supports the assertion that Plaintiff suffered from lupus that caused physical symptoms that contributed to her being disabled. MetLife argues that Plaintiff's medical experience should not serve as a "free card of now I never have to work again" and cites a professional baseball player and a former President as examples of individuals able to function with a medical condition. (BT 39:1; Def. Br. p. 15 (noting that Tim Raines had lupus and continued to play baseball and that the late President Franklin D. Roosevelt continued to stay in office despite his medical condition)). This Court does not view the mere diagnosis of lupus as a disability that requires LTD benefits. Rather it is the extent of the symptoms associated with lupus that render one disabled. MetLife cannot ignore the fact that Plaintiff has both the condition and the associated symptoms because MetLife determined Plaintiff was disabled in 2009 due to this very medical condition. (AR 1271, 1281, 1290.) The Court also rejects the inference MetLife draws from its examples because if MetLife's logic was correct then Plaintiff would have not received any LTD benefits to begin with.
The Court questions whether due consideration was given to Plaintiff's overall medical history.
Another notable point is that Dr. Marwah's opinion predominantly draws from Dr. Shinada's August 2012 and November 2012 reports, but reaches a different overall conclusion than Dr. Shinada. (AR 153 ("While Dr. Shinada writes in his report 11/27/12 that [Plaintiff] had ongoing severe fatigue, headaches, joint pain, and muscle pain, the report of 12/18/12 indicated that she was doing well.")). Dr. Marwah concludes
Dr. Shinada's August 20, 2012 and November 2, 2012 reports state that Plaintiff is stable and improving. (See AR 235) ("Doing well. Saw the patient last week. No headaches. No visual problems. No numbness, no tingling. No joint pain."; AR 778 ("[c]urrently doing well. [Plaintiff] is back to work")). MetLife argues that the medical records at the relevant time provide no description of disabling symptoms. (BT 23:15-17.) Yet, on November 27, 2012, MetLife received a letter from Dr. Shinada that stated that Plaintiff's condition was exacerbated because she began to work. (AR 767-68.) The letter explicitly says "[Plaintiff] cannot tolerate a full job. She is under a lot of stress and this causes a flare in her symptoms." (AR 767.) On November 19, 2012, Dr. Shinada completed a medical report, which also concluded that Plaintiff should not return to work full-time because working exacerbates her symptoms. (AR 770 ("I believe stress at work is exacerbating her symptoms, and keeping her out of work at this time would be the best option, in terms of treatment, to prevent further flares.")). While Dr. Shinada has opined that Plaintiff has improved in the past, MetLife is certainly not suggesting that the Court be bound to Dr. Shinada's reports in August 20, 2012 and November 2, 2012 in examining the record.
The Court understands that by the very nature of lupus, Plaintiff will likely have "good days" and "bad days." (AR 216.) For instance, focusing on November 2012, the Court notes that earlier in the month Dr. Shinada described Plaintiff's improvement, and later in the month, Dr. Shinada described Plaintiff's regression due to her return to work. (AR 778; 770.) The change in positions were a direct result of Plaintiff going to the emergency room on November 12, 2012, which Dr. Shinada believes is in relation to her symptoms. (AR 769.) This is similar to when Plaintiff worked for Colgate-Palmolive Company from May 2007 to August 2009 where Plaintiff's symptoms caused her to stop working. (AR 1191, 1348-1349; 1403.) The Court can also point to events surrounding Plaintiff's LTD benefits reinstatement. (AR 823-828; 855.) After receiving Dr. Shinada's records that reported Plaintiff's steady improvement, MetLife terminated Plaintiff's LTD benefits in February 2012. (AR 875.) On appeal, after Dr. Shinada opined that "[w]orking under stress tends to exacerbate [Plaintiff's] symptomatology and may make her disease stay worse," MetLife reinstated Plaintiff's benefits plan in May 2012. (AR 855; 875.) With these events in mind, the Court can surely point to a period of time where Plaintiff was stable or when Dr. Shinada changed his medical stance regarding Plaintiff's condition. However, because Plaintiff is stable at various points does not mean that the debilitating symptoms will not be exacerbated if Plaintiff returns to work on a full-time basis.
Additionally, Plaintiff argues that her SSDI benefits should have been given deference in supporting Plaintiff's claim. (See Pl Reply.) MetLife's policy requires Plaintiff to apply for the SSDI benefits. (AR 48-51.) During the course of Plaintiff's initial LTD benefits plan, MetLife offset its benefits plan with Plaintiff's SSDI benefits. (AR 1455.) However, according to MetLife, no deference was given to the social security administration's
A similar circumstance was presented in Schramm, where the Court concluded that the SSDI benefits do suggest some limitation in the plaintiff's ability to work. Schramm, 718 F.Supp.2d at 1165. Here, the Senior Attorney Advisor of the Social Security Administration determined that Plaintiff was disabled, under the Social Security Act, since August 18, 2009. (AR 849.) MetLife correctly notes that no deference needs to be provided to Plaintiff's SSDI claim. The standards of the Plan and the standards of the Social Security Administration likely differ, but that does not mean that the decision should be disregarded in its entirety. Mossler v. Aetna Life Ins. Co., CV 13-01945 SJO (MRWx), 2014 WL 3587511, at *16, 2014 U.S. Dist. LEXIS 89046, at *45 (C.D.Cal. July 21, 2014) (considering the plaintiff's SSDI award because the decision constituted additional support in determining plaintiff's benefit entitlement. (citing Schramm, 718 F.Supp.2d at 1165)). Albeit with the distinction in standards, Plaintiff's SSDI award suggests that she bears some restriction in her capability to work. The Court acknowledges that this award is not dispositive, but the SSDI award does help Plaintiff's showing that she is disabled.
Under de novo review, the Court reviews the entire record while affording no deference to MetLife's prior decisions. See Opeta, 484 F.3d at 1217. MetLife concluded that Plaintiff is not disabled based on the opinion of a independent physician that minimally corresponded with the treating physician, did not conduct an in-person examination, and focused on particular time period without considering the entire record. On the other hand, Dr. Shinada has supplemented the record with reports, objective and subjective, that indicate that Plaintiff suffers from a chronic illness that worsens when she works on a full-time basis. Moreover, Dr. Shinada has stated that the November 2012 incident was interrelated to Plaintiff's condition and recommended she not work for a year. (AR 767.) The Court understands that none of these events are decisive, individually. However, taking the entire record into account, the Court is hard-pressed not to find Dr. Shinada's reports more influential, especially in light of MetLife's past determination that Plaintiff was disabled. See McOsker, 279 F.3d at 589 ("[U]nless information available to an insurer alters in some significant way, the previous payment of benefits is a circumstance that must weigh against the propriety of an insurer's decision to discontinue those payments.").
Finally, based on the AR, the Court finds that Plaintiff is unable to participate in any occupation, to which she qualifies.
Plaintiff claims that her return to work was short lived because of the high stress levels at her job and her lupus condition. (Pl. Br., p. 2.) Plaintiff believes that MetLife is terminating her based on her unsuccessful attempt to return back to work. (Pl. Reply, p. 16.) Plaintiff relies on Paul Broadus, a vocational expert with Broadus & Associates. (AR 698-706.) Mr. Broadus concluded, through his Employability Analysis, "due to the abnormal exam findings, diagnostic test results and documented restrictions and limitations reported by Dr. Shinada, she is prevented from working in even a sedentary occupation, and is therefore unable to perform the materials duties of any occupation." (Id.)
Based on the record before it, the Court does not believe Plaintiff could perform either the essential duties at her own occupation or the essential duties of any occupation to which she is reasonably qualified, taking into account her training, education, and experience. As CorVel noted in its analysis, Plaintiff has a Bachelor of Science Degree in Marketing and has extensive work experience including, but not limited to, serving as a manager of sales and a sales service promoter. (AR 133.) Her skills and her qualifications speak to Plaintiff's ability to perform sedentary work. Perryman v. Provident Life & Accident Ins. Co., 690 F.Supp.2d 917, 948 (D.Ariz.2010) (elaborating on "sedentary work, as defined by the [Department of Labor's] Dictionary of Occupational Titles, `involves sitting most of the time....'"). Yet, CorVel does not provide an adequate explanation or examples of how Plaintiff is to perform the essential duties of an occupation with the limitations of her medical condition. Based on the record, it appears that Plaintiff has made numerous efforts to continue to work and has tried various jobs to no avail. It also appears, and Dr. Shinada confirms, that stress impacts Plaintiff's medical condition so severely that she needed to cease from working. With that in mind, the Court has difficulty envisioning a job similar in nature or one that she is reasonably qualified for that would not cause medical flare-ups to Plaintiff's lupus.
The Court is not convinced that Plaintiff can work any of these positions cited in CorVel's report, or any sedentary job, on a full-time basis because of a few notable facts. For instance, Plaintiff went to the emergency room working her last job, which indicates that her symptoms can severely affect her work to the point where she is missing workdays or she is hospitalized. (AR 216 (In filling out the Residual Functional Capacity Questionnaire, Dr. Shinada notes that on average Plaintiff is to miss work more than three (3) times a month.)). Additionally, Plaintiff is clearly limited in performing her occupational duties. In CorVel's employability and labor market analysis, CorVel partially relied on Dr. Marwah's opinion in
The Court is not convinced that Plaintiff can work any of the positions cited in the CorVel report and finds that the evidence within the AR is insufficient to support the termination of Plaintiff's benefits. Because the Court concludes that the evidence within the AR supports a finding of LTD benefits, Plaintiff is entitled to reinstatement of her LTD benefits until her condition significantly improves.
For the foregoing findings of fact and conclusions of law, Plaintiff is entitled to continue receive LTD benefits. Plaintiff shall submit a proposed judgment no later than a week from this ruling.